Derivative exercise or conversion — not an open-market buy.
Traded Oct 27, 2025 · Filed Oct 28, 2025
TransDigm Group's Co-Chief Operating Officer sold $786K of TransDigm Group shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$785,761
Shares × reported transaction price
83 days after results of Aug 5, 2025, 16 days before results of Nov 12, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,354.46 on Oct 27, 2025, 10% above its 52-week low and 16% below its high, after a 5% rise over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 32% of the way up, from 250 adjusted closes. 30 trading days earlier: $1,288.13 on Sep 15, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.8% | -1.4% | -2.4% |
| 30 days | +3.4% | -0.6% | +3.9% |
| 90 days | +8.4% | +1.2% | +7.3% |
| 180 days | -12.0% | +4.0% | -16.0% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of TransDigm Group sold $5.57M of TransDigm Group shares. Nobody planned it ahead of time.
A board member of TransDigm Group sold $123K of TransDigm Group shares. Nobody planned it ahead of time.